Altrius Capital Management Inc Increases Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Altrius Capital Management Inc raised its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 39.9% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 249,487 shares of the pharmacy operator's stock after buying an additional 71,209 shares during the period. Altrius Capital Management Inc's holdings in Walgreens Boots Alliance were worth $3,018,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in WBA. Pineridge Advisors LLC purchased a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth about $26,000. Quest Partners LLC purchased a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth about $30,000. 1832 Asset Management L.P. increased its stake in shares of Walgreens Boots Alliance by 282.1% during the fourth quarter. 1832 Asset Management L.P. now owns 1,219 shares of the pharmacy operator's stock worth $32,000 after purchasing an additional 900 shares in the last quarter. New Covenant Trust Company N.A. acquired a new position in Walgreens Boots Alliance during the first quarter worth about $35,000. Finally, First Personal Financial Services boosted its position in Walgreens Boots Alliance by 260.0% during the first quarter. First Personal Financial Services now owns 1,800 shares of the pharmacy operator's stock worth $39,000 after acquiring an additional 1,300 shares during the last quarter. Hedge funds and other institutional investors own 58.59% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Truist Financial lowered their price target on shares of Walgreens Boots Alliance from $20.00 to $13.00 and set a "hold" rating on the stock in a research report on Friday, June 28th. UBS Group lowered their price target on shares of Walgreens Boots Alliance from $17.00 to $12.00 and set a "neutral" rating on the stock in a research report on Wednesday, July 3rd. Bank of America lowered their price target on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an "underperform" rating on the stock in a research report on Wednesday, September 4th. Evercore ISI lowered their price target on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an "in-line" rating on the stock in a research report on Friday, June 28th. Finally, Morgan Stanley decreased their target price on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set an "underweight" rating on the stock in a report on Friday, June 28th. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $14.73.

Walgreens Boots Alliance Trading Down 0.3 %

Shares of WBA stock traded down $0.03 during trading hours on Thursday, hitting $8.98. The company had a trading volume of 14,547,124 shares, compared to its average volume of 16,101,119. The company's fifty day moving average is $10.40 and its 200 day moving average is $14.89. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.65 and a quick ratio of 0.31. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.46 and a fifty-two week high of $27.05. The stock has a market capitalization of $7.75 billion, a PE ratio of -1.35, a price-to-earnings-growth ratio of 1.02 and a beta of 0.70.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $0.63 EPS for the quarter, missing the consensus estimate of $0.68 by ($0.05). Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The company had revenue of $36.40 billion during the quarter, compared to analyst estimates of $35.94 billion. During the same quarter in the prior year, the company posted $1.00 earnings per share. The business's revenue was up 2.8% compared to the same quarter last year. Research analysts expect that Walgreens Boots Alliance, Inc. will post 2.86 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 12th. Investors of record on Wednesday, August 21st were paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 11.14%. The ex-dividend date was Wednesday, August 21st. Walgreens Boots Alliance's payout ratio is currently -14.84%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.